Literature DB >> 19229521

Nicotinic receptors differentially modulate the induction and expression of behavioral sensitization to methylphenidate in rats.

Thomas E Wooters1, Michael T Bardo.   

Abstract

RATIONALE: Nicotinic acetylcholine receptors (nAChRs) regulate sensitization to stimulant drugs such as d-amphetamine and cocaine.
OBJECTIVES: The current study determined if nAChRs modulate the induction and/or expression of behavioral sensitization to high methylphenidate doses.
METHODS: In experiment 1, rats received saline or mecamylamine (3 mg/kg, sc), followed by saline or methylphenidate (5.6 or 10 mg/kg, sc) during 10 daily sessions; the effect of methylphenidate (1-17 mg/kg, sc) alone was determined 14 days later. In experiment 2, rats received saline or dihydro-beta-erythroidine (DHbetaE; 3 mg/kg, sc), followed by saline or 5.6 mg/kg of methylphenidate. In experiment 3, rats received saline or methylphenidate (5.6 or 10 mg/kg, sc) alone for 10 days; the effect of acute mecamylamine (3 mg/kg, sc) on the response to methylphenidate (1-17 mg/kg, sc) was determined 14 days later. Locomotor activity, sniffing, rearing, grooming, and stereotypy ratings were dependent measures.
RESULTS: Methylphenidate produced dose-dependent increases in locomotor activity, sniffing, and stereotypy on day 1 and these effects were enhanced on day 10, indicative of sensitization. Mecamylamine attenuated methylphenidate-induced stereotypy only on day 1, but reduced locomotor activity, sniffing, rearing, and stereotypy on day 10 and during the methylphenidate challenge phase; similar results were obtained with DHbetaE. However, acute mecamylamine did not alter the effects of the methylphenidate challenge following the induction of sensitization to methylphenidate alone.
CONCLUSIONS: Although nAChRs do not appear to regulate the expression of methylphenidate-induced behavioral sensitization, inhibition of high-affinity beta2 subunit nAChRs attenuates the induction of behavioral sensitization to high doses of methylphenidate.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19229521      PMCID: PMC2682633          DOI: 10.1007/s00213-009-1487-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  73 in total

Review 1.  Presynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmission.

Authors:  R Exley; S J Cragg
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

Review 2.  The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.

Authors:  Sharon R Grady; Outi Salminen; Duncan C Laverty; Paul Whiteaker; J Michael McIntosh; Allan C Collins; Michael J Marks
Journal:  Biochem Pharmacol       Date:  2007-07-27       Impact factor: 5.858

3.  Effects of inattention and hyperactivity/impulsivity symptoms on development of nicotine dependence from mid adolescence to young adulthood.

Authors:  Daniel Rodriguez; Kenneth P Tercyak; Janet Audrain-McGovern
Journal:  J Pediatr Psychol       Date:  2007-10-23

4.  Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.

Authors:  Klas R Linderholm; Alexandra Andersson; Sara Olsson; Elin Olsson; Ralph Snodgrass; Göran Engberg; Sophie Erhardt
Journal:  Neuropharmacology       Date:  2007-09-20       Impact factor: 5.250

5.  5-HT 1B receptor-mediated serotoninergic modulation of methylphenidate-induced locomotor activation in rats.

Authors:  Janusz Borycz; Agustin Zapata; César Quiroz; Nora D Volkow; Sergi Ferré
Journal:  Neuropsychopharmacology       Date:  2007-05-09       Impact factor: 7.853

Review 6.  The role of acetylcholine in cocaine addiction.

Authors:  Mark J Williams; Bryon Adinoff
Journal:  Neuropsychopharmacology       Date:  2007-10-10       Impact factor: 7.853

7.  Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons.

Authors:  J Russel Keath; Michael P Iacoviello; Lindy E Barrett; Huibert D Mansvelder; Daniel S McGehee
Journal:  J Neurophysiol       Date:  2007-10-17       Impact factor: 2.714

Review 8.  Neuronal nicotinic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: focus on cognition.

Authors:  Timothy E Wilens; Michael W Decker
Journal:  Biochem Pharmacol       Date:  2007-07-07       Impact factor: 5.858

9.  Methylphenidate enhances the abuse-related behavioral effects of nicotine in rats: intravenous self-administration, drug discrimination, and locomotor cross-sensitization.

Authors:  Thomas E Wooters; Nichole M Neugebauer; Craig R Rush; Michael T Bardo
Journal:  Neuropsychopharmacology       Date:  2007-06-20       Impact factor: 7.853

10.  Attention deficit hyperactivity disorder symptoms predict nicotine dependence and progression to regular smoking from adolescence to young adulthood.

Authors:  Bernard F Fuemmeler; Scott H Kollins; F Joseph McClernon
Journal:  J Pediatr Psychol       Date:  2007-06-30
View more
  3 in total

1.  Methylphenidate attenuates rats' preference for a novel spatial stimulus introduced into a familiar environment: assessment using a force-plate actometer.

Authors:  Stephen C Fowler; Troy J Zarcone; Beth Levant
Journal:  J Neurosci Methods       Date:  2010-03-25       Impact factor: 2.390

2.  Reduced striatal dopamine D1-D2 receptor heteromer expression and behavioural subsensitivity in juvenile rats.

Authors:  M L Perreault; A Hasbi; M Alijaniaram; B F O'Dowd; S R George
Journal:  Neuroscience       Date:  2012-09-15       Impact factor: 3.590

3.  The whisker nuisance task identifies a late-onset, persistent sensory sensitivity in diffuse brain-injured rats.

Authors:  Katelyn C S McNamara; Amanda M Lisembee; Jonathan Lifshitz
Journal:  J Neurotrauma       Date:  2010-04       Impact factor: 5.269

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.